Practice Management

COVID-19 Vaccines: AstraZeneca Resumes Trial; Pfizer, BioNTech Look to Expand Study

By

Diana Ernst, RPh

AstraZeneca has resumed a phase 3 clinical trial investigating AZD1222, its COVID-19 vaccine candidate.

HHS Authorizes Pharmacists to Administer Vaccines to Children

HHS issued the amendment in order to increase access to childhood vaccines and decrease the risk of vaccine-preventable disease outbreaks as children return to daycare and school.

Guidance May Help Doctors Optimize Telemedicine for Seniors

Guidance is provided for physicians to optimize telemedicine, which can be challenging for older patients.

Trial Investigating COVID-19 Therapy in Long-Term Care Facilities Begins

A phase 3 trial evaluating LY-CoV555 for the prevention of SARS-CoV-2 infection and COVID-19 in residents and staff of long-term care facilities has been initiated.

Cost-Related Prescription Nonadherence Highest in Young Women in the US

Cost-related prescription nonadherence is highest among younger US women compared with individuals living in 10 other high-income countries.

What Would an Ethical COVID-19 Immunity Passport Program Look Like?

Immunity passport policies for COVID-19 should be communicated as stop-gap measures within wider, multipronged approaches to help society transition out of restrictive measures.

Phase 3 Trial of COVID-19 Vaccine Candidate mRNA-1273 Begins

Phase 3 trial initiated evaluating the vaccine candidate mRNA-1273 against COVID-19.

Pfizer, BioNTech Sign Deal for 100 Million COVID-19 Vaccine Doses

The US Department of Health and Human Services and the Department of Defense have agreed to receive 100 million doses of BNT162, a vaccine for SARS-CoV-2, once the manufacturers obtains approval or emergency use authorization (EUA) from the FDA

Lack of Public Education for Using Face Masks Leads to Noncompliance, Experts Warn

A nationwide, coordinated effort is needed to successfully implement widespread wearing of face masks to help slow the spread of COVID-19.

Call for “Challenge Trials” to Hasten COVID-19 Vaccine Development

The US government should make immediate preparations for clinical trials in which volunteers are exposed to the new coronavirus to speed development of a vaccine.

Immune Responses Observed in All Participants Who Received Moderna’s COVID-19 Vaccine Candidate

Participants demonstrated high levels of neutralizing antibody activity that exceeded those seen in convalescent sera obtained from persons with confirmed COVID-19.